yemenjmedYemen Journal of MedicinecoVolume 1 Issue 2MultidisciplinaryEnglishJuly - December 2022NNY20250328ArticleExtracorporeal membrane oxygenation: Is it another slower way to die?EnglishY5658Abdulsalam SaifIbrahimEnglishNTasleemRazaEnglishYJuliaGibsonEnglishYIbrahim FawzyHassanEnglishYBruce LDavidsonEnglishY10.32677/yjm.v1i2.3638Extracorporeal membrane oxygenation (ECMO) is an advanced respiratory support that is being adopted as salvage therapy in acute respiratory failure [1]. The widespread use of this technology came as a result of a large multicenter randomized UK study showing a survival benefit for severe acute respiratory distress syndrome (ARDS) patients transferred to an ECMO-capable specialist center [2]. Moreover, improvements in clinical management and advances in technology have gradually changed ECMO from a “rescue therapy of last resort” to a type of standardized therapy for severe impairment with clear indications and contraindications in many specialized centers around the globe, including for the treatment of COVID-19 patients.Englishhttps://yemenjmed.com/admin/abstract?id=29References16191. Fielding-Singh V, Matthay MA, Calfee CS. Beyond low tidal volume ventilation: treatment adjuncts for severe respiratory failure in acute respiratory distress syndrome. Crit Care Med 2018 46:1820-31.2. Butt W, Maclaren G. Extracorporeal membrane oxygenation. F1000Prime Rep 2013;5:55.3. Abrams DC, Prager K, Blinderman CD, et al. Ethical dilemmas encountered with the use of extracorporeal membrane oxygenation in adults. Chest 2014;145:876-82.4. Sikkema RS, Farag EA, Himatt S, et al. Risk factors for primary middle east respiratory syndrome coronavirus infection in camel workers in qatar during 2013-2014: A case-control study. J Infect Dis 2017;215:1702-5.